II. Epidemiology
- Prevalence: 1-7% in general U.S. population (increased over age 50 years)
 
III. Pathophysiology: Injury affects one of four components
- See Neuron
 - 
                          Neuronal or Axonal Neuropathy
- Affects cell body or axon of nerve
 - See Symmetric Peripheral Neuropathy (Polyneuropathy)
 - See Asymmetric Peripheral Neuropathy (Mononeuropathy)
 - See Peripheral Nerve Injury
 - Diabetes Mellitus
 - Collagen vascular disease Vasculitis
 - Thyroid disease
 - Vitamin Deficiency (e.g. Vitamin B12 Deficiency)
 - Hereditary Neuropathy
 
 - Demyelinating Neuropathy (Myelinopathy)
- Affects myelin swan cell sheath around axon
 - Symmetric Peripheral Neuropathy (Polyneuropathy)
- Consider hereditary Neuropathy
 
 - Asymmetric Peripheral Neuropathy (Mononeuropathy)
- Acute Demyelinating Neuropathy (e.g. Guillain Barre Syndrome)
 - Chronic Inflammatory Demyelinating Polyneuropathy
 
 
 - Infiltrative Neuropathy: Affects supporting tissue
- Appears similar to demyelinating Neuropathy
 - Sarcoidosis
 - Myelomatosis
 - Amyloidosis
 
 - Ischemic Neuropathy: Affects nerve vascular supply
- Diabetes Mellitus
 - Collagen vascular disease
 
 
IV. Pathophysiology: Nerve Fiber Size
- Large Nerves
- Carry motor and sensory, as well as proprioception and vibration sense
 
 - Small Nerves
- Carry pain and Temperature, as well as Autonomic System signals
 
 
V. History
- What is the distribution of nerve involvement?
- Symmetric: Polyneuropathy
- Usually due to systemic or hereditary condition
 - Idiopathic in 20% of cases
 
 - Asymmetric: Mononeuropathy
- Usually due to nerve compression or inflammation
 - Mononeuropathy: Isolated to a single nerve
 - Mononeuropathy Multiplex: >1 discrete nerve
 
 
 - Symmetric: Polyneuropathy
 - Is the deficit sensory, motor or sensorimotor?
- Most neuropathies affect both sensory and motor
 - Pure motor or sensory seen in distal Mononeuropathy
 - Is motor more than sensory involvement?
- Amyotrophic Lateral Sclerosis
 - Poliomyelitis or other chronic infectious cause
 - Hereditary sensorimotor Neuropathy
 - Toxin exposure
 
 - Is sensory more than motor involvement?
- Toxin exposure
 - Vitamin B12 Deficiency
 - Hereditary sensory Neuropathy
 - Systemic condition
- Diabetes Mellitus
 - Uremia
 - Myelomatosis
 - Dysproteinemia
 
 
 
 - Are Cranial Nerves Involved (e.g. speech, Swallowing, facial, Tongue or neck weakness)?
- Diabetes Mellitus
 - Guillain Barre Syndrome
 - HIV Infection
 - Lyme Disease
 - Diphtheria
 - Sarcoidosis
 - Tumor invasion of Meninges or skull base
 
 - Is there Autonomic Dysfunction (Orthostasis, Gastroparesis, Erectile Dysfunction, bowel or Bladder changes)?
- Amyloidosis
 - Diabetes Mellitus
 - Lymphoma
 - Paraneoplastic Syndromes
 - Porphyria
 - Heavy Metal Toxicity (e.g. thallium, Arsenic, Mercury Poisoning)
 
 - Are upper extremities predominately affected?
- Amyloidosis (hereditary type II amyloid Neuropathy)
 - Diabetes Mellitus
 - Familial Motor Sensory Neuropathy
 - Guillain Barre Syndrome
 - Lead Toxicity
 - Porphyria
 - Vitamin B12 Deficiency
 
 - When was the onset of symptoms?
- Acute over hours or days
- Consider Trauma, ischemia, Vasculitis
 - Motor Neuropathy most common
- See Acute Motor Weakness Causes
 - Acute motor loss is risk for Respiratory Failure (e.g. Guillain Barre Syndrome)
 - Requires urgent evaluation
 
 - Sensory Neuropathy: Herpes Zoster
 
 - Subacute over days to weeks
 - Chronic over months to years
- Accounts for most cases of Neuropathy
 - Consider Medication Causes of Neuropathy, and metabolic disorders
 
 
 - Acute over hours or days
 - Other related history
- Infectious Disease Risks
- HIV Infection risks
 - Lyme Disease risks
 
 - Medications
- See Medication Causes of Neuropathy
 - Also review herbal use
 
 - Family History
- Neurologic disorders (familial Neuropathy) or skeletal deformity
 
 - Exposures
- Travel History
 - Work exposure (e.g. Heavy Metal exposure)
 - Recent Immunizations (e.g. Guillain Barre Syndrome associations)
 
 - Past Medical History
 - New bowel and Bladder dysfunction (e.g. Incontinence, retention)
- Associated with central Neuropathy causes (e.g. Cauda Equina Syndrome)
 
 
 - Infectious Disease Risks
 
VI. Exam
- Perform thorough evaluation, including cardiopulmonary exam and skin exam
 - Complete Neurologic Exam (see specific signs below)
- See Neurologic Exam
 - See Sensory Exam
 - See Motor Exam
 - See Deep Tendon Reflex
 
 
VII. Signs: Sensory
- Specific Sensory Exam features
- Evaluate for common compression neuropathies (e.g. sciatic nerve, lateral femoral cutaneous, Median Nerve)
 - Identify affected Dermatome(s) including over the trunk, comparing to the opposite side
 - Include vibratory Sensation (128 Hz tuning fork) and monofilament (10-g)
 
 - Pathognomonic neuropathic findings
- Allodynia (pain from non-painful stimulus - such as light touch)
 - Hyperalgesia (excessive pain from a painful stimulus)
 
 - Demyelinating or infiltrative Neuropathy
- Loss of vibration sense
 - Loss of joint position sense
 - Loss of tactile discrimination
 
 - 
                          Axonal Neuropathy
                          
- Sensory modes affected equivalently
 - Neuropathy begins distally and moves proximally
 - Injured Nerve Cell body cannot pump to axon end
 - Results in stocking-and-glove distribution
 - Long axons (e.g. legs) lose distal function first
- First: Sensory loss begins in feet
 - Next: Deficit progresses proximally to knees
 - Next: Hands begin to lose Sensation
 - Face is rarely affected (generally short axons)
 
 
 
VIII. Signs: Motor
- Specific Motor Exam features
- Stand-Squat-Stand with arms flexed forward in front
- Identifies subtle proximal Muscle Weakness
 
 - Unilateral heal raise (arms against wall for support)
- Identifies subtle calf weakness
 
 
 - Stand-Squat-Stand with arms flexed forward in front
 - Demyelinating or infiltrative Neuropathy
- Early loss of Deep Tendon Reflexes
 - Sensory often affected more than motor function
 
 - 
                          Axonal Neuropathy
                          
- Initial: Damage to anterior horn cell at spinal cord
- Weakness
 - Muscle wasting
 - Muscle Fasciculations
 
 - Later
- Deep Tendon Reflex loss in chronic Neuropathy
 - Demyelination may occur secondary to axonal loss
- Differentiate from primary demyelination as above
 
 
 - Motor loss follows same pattern as for sensory loss
- Distal affected before proximal involvement
 
 
 - Initial: Damage to anterior horn cell at spinal cord
 
IX. Causes
- See Medication Causes of Neuropathy
 - See Symmetric Peripheral Neuropathy (Polyneuropathy)
 - See Asymmetric Peripheral Neuropathy (Mononeuropathy)
 - Most common causes
- Idiopathic in >25% of cases
 - Diabetes Mellitus (25-50% of diabetic patients)
 - Alcoholic Neuropathy
 - Nerve compression or injury
 - Toxin exposure
 - Hereditary Neuropathy causes
 - Nutritional Deficiency (e.g. Vitamin B12 Deficiency)
 
 - Painful Neuropathy causes
- Alcoholic Neuropathy
 - Amyloidosis
 - Chemotherapy
 - Diabetic Neuropathy (25-50% of diabetic patients)
 - Porphyria
 
 - Neuropathy with autonomic findings
- All painful neuropathies also cause autonomic features
 - Paraneoplastic Syndrome
 - Heavy Metal Toxicity
 - Vitamin B12 Deficiency
 
 
X. Differential Diagnosis: Central Neuropathy
- Central Neuropathy causes
- Myelopathy
 - Spinal Cord Syndromes (e.g. syringmyelia, Trauma, Tabes Dorsalis)
 - Upper Motor Neuron or Central Nervous System disorder
 - Cerebrovascular Accident
 
 - Findings that may distinguish central Neuropathy (from Peripheral Neuropathy)
- Bilateral sensory deficits with multiple Dermatomes affected
 - Motor deficits are often bilateral (below the level of the lesion)
 - Upper Motor Neuron Deficit (spasticity, hyperreflexia, Clonus)
 - Bowel and Bladder dysfunction may be present (e.g. Cauda Equina Syndrome)
 - Loss of Sensation rather than the altered Sensation of Peripheral Neuropathy (hyperesthesia, Paresthesia)
 
 
XI. Labs: Initial
- Complete Blood Count (CBC)
 - Comprehensive metabolic panel (includes Electrolytes, Liver Function Tests, Renal Function tests)
 - Erythrocyte Sedimentation Rate or C-Reactive Protein (C-RP)
 - Fasting Blood Glucose (or Hemoglobin A1C)
 - Thyroid Stimulating Hormone
 - Serum Vitamin B12
 
XII. Labs: Axonal Neuropathy Suspected
- First-line
- Hemoglobin A1C
 - HIV Test
 - Lyme Antibody test
 - Rapid Plasma Reagin (RPR) or VDRL
 - Antinuclear Antibody (ANA)
 - P-ANCA and C-ANCA
 
 - Second-line (if first-line tests negative or suggest additional specific testing)
- Serum Protein Electrophoresis (SPEP)
 - Urine Protein Electrophoresis (UPEP)
 - Urine 24 hour collection for Heavy Metals and porphyria
 - Paraneoplastic Syndrome testing
 
 
XIII. Diagnostics
- Indications
- Testing indicated if persistent symptoms or unclear etiology
 - Distinguishes axonal and demyelinating types of Peripheral Neuropathy
 
 - 
                          General
- EMG and NCS used in combination
 - Differentiate axonal from myelin-infiltrative cause
 - See Nerve Conduction Velocity for Interpretation
 
 - Nerve and Muscle Transmission
- Indications
- Nondiagnostic workup for persistent Neuropathy
 - Demyelinating condition suspected
 - Acute asymmetric, motor or Autonomic Neuropathy
 
 - Needle Electromyography (EMG)
 - Nerve Conduction Studies (Nerve Conduction Velocity, NCS)
 
 - Indications
 - Nerve biopsy
- Vasculitis
 - Amyloidosis
 - Sarcoidosis
 - Leukodystrophy
 - Chronic Inflammatory demyelinating Neuropathy
 
 - Additional studies (not commonly indicated)
 
XIV. Evaluation
- Obtain initial labs above
 - Treat specific evident causes (e.g. Diabetic Neuropathy)
 - If symptoms persist, obtain diagnostic studies above
 - Type of Neuropathy based on EMG
- Axonal
- Consider second-line and third-line lab testing as listed above
 
 - Demyelinating
- Uniform: Hereditary Neuropathy
 - Nonuniform
- Acute: Guillain-Barre Syndrome
 - Subacute or Chronic: Chronic Inflammatory Demyelinating Polyneuropathy
 
 
 
 - Axonal
 
XV. Precautions: Red Flags
- Progressive ascending weakness (risk of Respiratory Failure, e.g. Guillain Barre Syndrome)
 - 
                          Central Nervous System Lesion Symptoms
- Altered speech or Swallowing
 - Ataxia or Double Vision
 - Hemiparesis or Hemiplegia
 - Altered bowel or Bladder function (new retention or Incontinence)
 - Cranial Nerve Deficit
 
 
XVI. Management
- Neurology Consultation indications
- Nondiagnostic Neuropathy evaluation
 - Acute or subacute, severe or progressive Neuropathy
 - Polyneuropathy or multifocal Neuropathy
 - Pure motor Neuropathy
 - Autonomic Neuropathy
 
 - 
                          General Measures
- Neuropathic pain tends to be worse at night (when less distracted or trying to initiate sleep)
 - Consider physical therapy
 - Weight loss
 - Eliminate provocative activities (e.g. Compression Neuropathy, poor footwear)
 - Non-specific measures
- Warm soaks
 - Moisturizing rubs
 - Desensitizing massage
 
 
 - First-line medications: Tricyclic Antidepressants (NNT 3-4)
- Desipramine
 - Amitriptyline or Nortriptyline
- Start at 10-30 mg at bedtime
 - Goal dose 75-100 mg nightly
 
 
 - Second-line medications: SNRI (NNT 6-7)
- Duloxetine (Cymbalta)
- Goal dose 60 mg daily
 
 - Venlafaxine
 
 - Duloxetine (Cymbalta)
 - Third-line medications (NNT 7-8)
- Gabapentin (Neurontin)
- Goal dose 1800-3600 daily divided three times daily
 
 - Pregabalin (Lyrica)
- Goal dose 300-600 mg daily divided twice daily
 
 
 - Gabapentin (Neurontin)
 - Additional measures
- Consider combining medications listed above
 - Lidocaine Patch
 
 - Other medications (typically started by neurology)
- Lamotrigine
 - Topomax
 - Carbamazepine
 
 
XVII. References
- Della-Giustina (2024) Crit Dec Emerg Med 38(10): 27-34
 - Gallagher in Marx (2002) Rosen's Emergency Med, p. 1506
 - Pryse-Phillips in Noble (2001) Primary Care, p. 1579
 - Azhary (2010) Am Fam Physician 81(7): 887-92 [PubMed]
 - Castelli (2020) Am Fam Physician 102(12): 732-9 [PubMed]
 - Finnerup (2015) Lancet Neurol 14(2): 162–73 [PubMed]
 - Hughes (2002) BMJ 324(7335): 466-9 [PubMed]